BackGlenmark Pharmaceuticals Limited Overview

Glenmark Pharmaceuticals Limited Receivables

Latest receivables for GLENMARK.BO: $50B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$49.63B
↑ 18.71% YoYΔ $7.82B vs prior year quarter

Peer trimmed avg / median

Loading

Glenmark Pharmaceuticals Limited Receivables History

Loading

Glenmark Pharmaceuticals Limited vs. peers: Receivables Comparison

Loading

Glenmark Pharmaceuticals Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Glenmark Pharmaceuticals Limited (GLENMARK.BO) FAQ

Glenmark Pharmaceuticals Limited (GLENMARK.BO) currently reports a receivables of $50B as of March 2026. That compares with $42B in the prior-year period — up 18.7% year over year. Use the charts on this page to explore Glenmark Pharmaceuticals Limited's receivables history and peer comparisons.

Glenmark Pharmaceuticals Limited's receivables increased from $42B to $50B — a 18.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Glenmark Pharmaceuticals Limited reported $50B in receivables as of March 2026. That compares with $42B in the prior-year period — up 18.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $50B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Glenmark Pharmaceuticals Limited, and consider following GLENMARK.BO for alerts when major investors trade the stock.